Harvard Business Review

MAY 20, 2014

The rate of business formation in 2011 was almost half of what it was in 1978, with the rate of dissolution somewhat higher than the past couple decades. This paper by the Richmond Fed shows how from 1960 to 2005, the U.S. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers.

Pharmaceuticals 11

Pharmaceuticals Banking Chemicals Trends 11

Harvard Business Review

DECEMBER 12, 2012

Based on data covering the period from 2005 to 2011, it charts how globalization has evolved since the onset of the financial crisis at the global, regional, and national levels. Countries' levels of global connectedness are impacted both by their domestic and their foreign policies.

Report 15

Report Merchandising GDP Globalization 15

Harvard Business Review

FEBRUARY 15, 2012

While Guangdong's exports accounted for as much as 37% of China's exports by 2000, its share dropped to 28% in 2011. The province's exports growth rate, which was 26% in 2010, fell to 22% in the first nine months of 2011, and it has continued to decline ever since.

GDP 12

GDP Pharmaceuticals Long-term Globalization 12

Terry Starbucker

SEPTEMBER 30, 2010

No, not the pharmaceutical kind. This pill is invisible, and sits on our bed stands every morning, waiting for us to pop it into our brain. I forgot to take my happy pills.

Pharmaceuticals 243

Pharmaceuticals Ethics Self-aware Blog 243

Harvard Business Review

JUNE 29, 2015

Their sample included 35,081 firms and 407 buyouts that took place between 1998 and 2005. This is consistent with a 2011 article in the Journal of Finance, which also found that “patents of private equity-backed firms applied for in the years after the investment are more frequently cited.”

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

FEBRUARY 24, 2015

We are not saying that rapid ownership change is a requirement for business success—quite to the contrary, it is often a corollary.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. This lab isn't located in Bangalore or Hyderabad (where Dr Reddy's is headquartered) but in.

Globalization 9

Globalization Innovation Decentralization Chemicals 9